← Leaderboards
Fekadu Kassie
University Of Minnesota
$5,236,992
Attributed
$5,236,992
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $699.3K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,236,992 · 5
By mechanism
R01$4,883,250 · 4
R21$353,742 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Stephen S Hecht$48,780,026
- Irina Stepanov$11,468,606
- Samir S Khariwala$2,671,862
- Chengguo Xing$6,408,898
- Robert J. Turesky$19,878,824
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungMalignant Neoplasm Of LungCarcinogensCellsCancer EtiologyLung TumorigenesisMalignant NeoplasmsChemopreventionCessation Of LifeTumorCancer CellProteinsTobacco SmokeSignal PathwayClinical TrialsApoptosisMediatingLung NeoplasmsButanonesMouse ModelA/J MouseCell ProliferationNeoplastic CellHigh Risk
Grant awards (18)
Targeting tumor cell mitochondria for the prevention and treatment of lung cancer$352,275
R01 · FY2025 · CA · contact PI
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells$345,230
R01 · FY2023 · CA · contact PI
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells$345,230
R01 · FY2022 · CA · contact PI
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells$352,275
R01 · FY2021 · CA · contact PI
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells$352,275
R01 · FY2020 · CA · contact PI
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells$352,275
R01 · FY2019 · CA · contact PI
Chemoprevention of inflammation-driven lung cancer$315,400
R01 · FY2017 · CA · contact PI
Chemoprevention of inflammation-driven lung cancer$315,400
R01 · FY2016 · CA · contact PI
Chemoprevention of inflammation-driven lung cancer$315,400
R01 · FY2015 · CA · contact PI
Chemoprevention of inflammation-driven lung cancer$305,938
R01 · FY2014 · CA · contact PI
Chemoprevention of inflammation-driven lung cancer$315,400
R01 · FY2013 · CA · contact PI
Lung carcinogenesis: Chemoprevention by Indole-3-carbinol$228,552
R01 · FY2013 · CA · contact PI
Diindolylmethane:Inhibition of lung squamous cell carcinoma by targeting Akt.$155,382
R21 · FY2013 · CA · contact PI
Lung carcinogenesis: Chemoprevention by Indole-3-carbinol$243,140
R01 · FY2012 · CA · contact PI
Diindolylmethane:Inhibition of lung squamous cell carcinoma by targeting Akt.$198,360
R21 · FY2012 · CA · contact PI
Lung carcinogenesis: Chemoprevention by Indole-3-carbinol$243,140
R01 · FY2011 · CA · contact PI
Lung carcinogenesis: Chemoprevention by Indole-3-carbinol$250,660
R01 · FY2010 · CA · contact PI
Lung carcinogenesis: Chemoprevention by Indole-3-carbinol$250,660
R01 · FY2009 · CA · contact PI